MyFinsight
Home
Blog
About
something is missing
$113K
Proceeds from the
exercise of stock options...
$30K
(-73.45%↓ Y/Y)
Net cash provided by
financing activities
$143K
(26.55%↑ Y/Y)
Net (decrease)
increase in cash and cash...
-$26,661K
(-920.09%↓ Y/Y)
Canceled cashflow
$143K
Accrued expenses
$1,660K
(39.15%↑ Y/Y)
Stock-based compensation
expense
$1,543K
(-51.42%↓ Y/Y)
Accounts payable
$389K
(109.77%↑ Y/Y)
Prepaid expenses and
other assets
-$253K
(92.01%↑ Y/Y)
Loss on sales and
disposals of fixed assets,...
-$25K
(34.21%↑ Y/Y)
Depreciation
$24K
(-65.22%↓ Y/Y)
Maturities of marketable
securities
$14,501K
(-83.21%↓ Y/Y)
Net cash used in
operating activities
-$14,577K
(60.14%↑ Y/Y)
Net cash provided by
investing activities
-$12,227K
(-130.80%↓ Y/Y)
Canceled cashflow
$3,894K
Canceled cashflow
$14,501K
Net loss
-$18,086K
(53.20%↑ Y/Y)
Purchases of marketable
securities
$26,728K
(-42.75%↓ Y/Y)
Accretion of discounts on
marketable securities
$382K
(-75.58%↓ Y/Y)
Non-cash lease income
$3K
(-25.00%↓ Y/Y)
Back
Back
Cash Flow
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP)
source: myfinsight.com